Genomics is expected to have a major impact on the way we conceptualize, prevent, diagnose and manage diseases, and promote health. Research and development of genome-related biotechnologies for health are accompanied by massive investments not only by industries but also by national governments as part of their strategies to promote innovation. As this field evolves there is a need for society to develop appropriate norms and frameworks to ensure that the complex social, ethical and economic issues of genomics are addressed. This should be done as early as possible, ideally as the technologies develop, and before applications based on the technologies have been marketed and introduced into health care systems. The course will address the main bioethical and public policy issues associated with genomics and health biotechnology development. It will discuss the current status of genomics science, genomics and biotechnology innovation systems, intellectual property rights, law and policy issues relating to genomics development, genomics and public health, public engagements, genomics and diversity, regenerative medicine, genomics databases, and the ethics of genomics in global context where important emerging principles such as benefit sharing will be discussed.